A rating of 97 puts Tempest Therapeutics Inc (TPST) near the top of the Biotechnology industry according to InvestorsObserver. Tempest Therapeutics Inc's score of 97 means it scores higher than 97% of stocks in the industry. Tempest Therapeutics Inc also received an overall rating of 81, putting it above 81% of all stocks. Biotechnology is ranked 62 out of the 148 industries.
TPST has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on TPST!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Tempest Therapeutics Inc Stock Today?
Tempest Therapeutics Inc (TPST) stock is down -5.57% while the S&P 500 has risen 0.54% as of 11:03 AM on Monday, Oct 30. TPST has fallen -$0.23 from the previous closing price of $4.22 on volume of 1,008,091 shares. Over the past year the S&P 500 has risen 6.91% while TPST has risen 115.68%. TPST lost -$2.41 per share the over the last 12 months.
Click Here to get the full Stock Report for Tempest Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
